Skip to content

Clinical trials

Terminated trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Status: Terminated Country / region: Hong Kong Clear all

270 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20043
20059
20065
200716
20089
200914
201013
201113
201217
201312
201415
20157
201612
201712
201821
201919
202021
202124
202214
20236
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated270

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong37
Novartis Pharmaceuticals27
Pfizer18
The University of Hong Kong13
Hoffmann-La Roche12
GlaxoSmithKline11
Amgen10
Gilead Sciences10
AstraZeneca8
Merck Sharp & Dohme LLC6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung22
Carcinoma, Hepatocellular16
Hepatitis B, Chronic15
Neoplasms15
Diabetes Mellitus, Type 214
Breast Neoplasms11
Crohn Disease10
Lung Neoplasms8
Neoplasm Metastasis8
Colorectal Neoplasms7

Trials

Showing 51 to 75 of 270. Each trial links to its page on Pharma Observatory.

170 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.